Cationic derivatives of biocompatible hyaluronic acids for delivery of siRNA and antisense oligonucleotides

Journal of Drug Targeting

Volumn 17, Issue 2, 2009, Pages 123-132

  Han, Su Eun ^a   Kang, Hyungu ^b   Shim, Ga Yong ^a   Kim, Sun Jae ^c   Choi, Han Gon ^d   Kim, Jiseok ^b   Hahn, Sei Kwang ^b   Oh, Yu Kyoung ^a  

^a Korea University   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

^c Sejong University   (South Korea)

^d Yeungnam University   (South Korea)

Author keywords

Antisense oligonucleotides; Cationic polymer; Hyaluronic acid; siRNA delivery

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GREEN FLUORESCENT PROTEIN; HYALURONIC ACID; MESSENGER RNA; OBLIMERSEN; POLYETHYLENEIMINE; PROTEIN BCL 2; SMALL INTERFERING RNA; SURVIVIN;

ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; CELL LINE; CELL STRAIN HEK293; CELL VIABILITY; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; GENE TARGETING; HELA CELL; HUMAN; HUMAN CELL; HYDRODYNAMICS; INHIBITION KINETICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ZETA POTENTIAL;

ANIMALS; CATIONS; CELL LINE, TUMOR; DRUG CARRIERS; GREEN FLUORESCENT PROTEINS; HUMANS; HYALURONIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; OLIGONUCLEOTIDES, ANTISENSE; POLYETHYLENEIMINE; RNA, SMALL INTERFERING;

EID: 58149473080     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860802472461     Document Type: Article

References (20)

1. de Fougerolles, AR (2008) Delivery vehicles for small interfering RNA in vivo. Hum Gene Ther, 19, pp. 125-132.
2. Dykxhoorn, DM, Palliser, D. and Lieberman, J. (2006) The silent treatment: SiRNAs as small molecule drugs. Gene Ther, 13, pp. 541-552.
3. Eter, N., Krohne, TU and Holz, FG (2006) New pharmacologic approaches to therapy for age-related macular degeneration. BioDrugs, 20, pp. 167-179.
4. Girish, KS and Kemparaju, K. (2007) The magic glue hyaluronan and its eraser hyaluronidase: A biological overview. Life Sci, 80, pp. 1921-1943.
5. Gomes dos Santos, AL, Bochot, A., Doyle, A., Tsapis, N., Siepmann, J., Siepmann, F., Schmaler, J., Besnard, M., Behar-Cohen, F. and Fattal, E. (2006) Sustained release of nanosized complexes of polyethylenimine and anti-TGF-beta 2 oligonucleotide improves the outcome of glaucoma surgery. J Control Release, 112, pp. 369-381.
6. Grayson, AC, Doody, AM and Putnam, D. (2006) Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro. Pharm Res, 23, pp. 1868-1876.
7. Grzelinski, M., Urban-Klein, B., Martens, T., Lamszus, K., Bakowsky, U., Hobel, S., Czubayko, F. and Aigner, A. (2006) RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts. Hum Gene Ther, 17, pp. 751-766.
8. Hough, SR, Clements, I., Welch, PJ and Wiederholt, KA (2006) Differentiation of mouse embryonic stem cells after RNA interference-mediated silencing of OCT4 and Nanog. Stem Cells, 24, pp. 1467-1475.
9. Ito, T., Iida-Tanaka, N., Niidome, T., Kawano, T., Kubo, K., Yoshikawa, K., Sato, T., Yang, Z. and Koyama, Y. (2006) Hyaluronic acid and its derivative as a multi-functional gene expression enhancer: Protection from non-specific interactions, adhesion to targeted cells, and transcriptional activation. J Control Release, 112, pp. 382-388.
10. Kogan, G., Soltes, L., Stern, R. and Gemeiner, P. (2007) Hyaluronic acid: A natural biopolymer with a broad range of biomedical and industrial applications. Biotechnol Lett, 29, pp. 17-25.
11. New, M., Gemershaus, O., Behe, M. and Kissel, T. (2007) Bioreversibly crosslinked polyplexes of PEI and high molecular weight PEG show extended circulation times in vivo. J Control Release, 124, pp. 69-80.
12. Noguchi, S., Hirashima, N., Furuno, T. and Nakanishi, M. (2003) Remarkable induction of apoptosis in cancer cells by a novel cationic liposome complexed with a bcl-2 antisense oligonucleotide. J Control Release, 88, pp. 313-320.
13. Noh, SM, Kim, WK, Kim, SJ, Kim, JM, Baek, KH and Oh, YK (2007) Enhanced cellular delivery and transfection efficiency of plasmid DNA using positively charged biocompatible colloidal gold nanoparticles. Biochim Biophys Acta, 1770, pp. 747-752.
14. Oh, YK, Kim, JP, Yoon, H., Kim, JM, Yang, JS and Kim, CK (2001) Prolonged organ retention and safety of plasmid DNA administered in polyethylenimine complexes. Gene Ther, 8, pp. 1587-1592.
15. Oh, YK, Suh, D., Kim, JM, Choi, HG, Shin, K. and Ko, JJ (2002) Polyethylenimine-mediated cellular uptake, nucleus trafficking and expression of cytokine plasmid DNA. Gene Ther, 9, pp. 1627-1632.
16. Peer, D. and Margalit, R. (2004) Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal Doxorubicin in syngeneic and human xenograft mouse tumor models. Neoplasia, 6, pp. 343-353.
17. Spagnou, S., Miller, AD and Keller, M. (2004) Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. Biochemistry, 43, pp. 13348-13356.
18. Stenvang, J. and Kauppinen, S. (2008) MicroRNAs as targets for antisense-based therapeutics. Expert Opin Biol Ther, 8, pp. 59-81.
19. Yadava, P., Roura, D. and Hughes, JA (2007) Evaluation of two cationic delivery systems for siRNA. Oligonucleotides, 17, pp. 213-222.
20. Yamato, K., Yamada, T., Kizaki, M., Ui-Tei, K., Natori, Y., Fujino, M., Nishihara, T., Ikeda, Y., Nasu, Y., Saigo, K. and Yoshinouchi, M. (2008) New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer. Cancer Gene Ther, 15, pp. 140-153.